Praxis Precision Medicines (PRAX) EPS (Basic) (2019 - 2026)
Praxis Precision Medicines' (PRAX) quarterly EPS (Basic) came in at -$19.46 in Q1 2026, down 440.29% year-on-year from $5.72 in Q1 2025, and down 8.5% quarter-over-quarter from -$17.94 in Q4 2025.
Praxis Precision Medicines (PRAX) EPS (Basic) (2019 - 2026) Analysis & Trends
Praxis Precision Medicines' EPS (Basic) history runs 8 years deep, the most recent figure standing at -$19.46 for Q1 2026.
- On a quarterly basis, EPS (Basic) fell 440.29% year-over-year to -$19.46 in Q1 2026; TTM through Mar 2026 was -$39.15, a 77.03% decrease from a year earlier, with the FY2025 full-year figure at -$32.71, down 39.97% from the prior year.
- EPS (Basic) slipped to -$19.46 in Q1 2026 per PRAX's latest filing, from -$17.94 in the prior quarter.
- Across five years, EPS (Basic) topped out at -$2.09 in Q2 2024 and bottomed at -$59.89 in Q4 2022.
- The 5-year median for EPS (Basic) is -$10.72 (2023), against an average of -$14.63.
- Across the five-year window, EPS (Basic) jumped 80.23% in 2023 and slumped 440.29% in 2026, its largest moves.
- Year by year, EPS (Basic) stood at -$59.89 in 2022, then soared by 47.26% to -$31.59 in 2023, then surged by 50.1% to -$15.76 in 2024, then dropped by 13.79% to -$17.94 in 2025, then retreated by 8.5% to -$19.46 in 2026.
- Per Business Quant, the three latest PRAX EPS (Basic) figures stand at -$19.46 (Q1 2026), -$17.94 (Q4 2025), and -$3.96 (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 0.00 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 0.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 0.16 |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 4.06 |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 6.99 |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 0.00 |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 5.90 |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | -2.29 |
| 10 | Praxis Precision Medicines | 9.37 Bn | 8.58 Bn | - | -19.46 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -19.46 |
| Dec 31, 2025 | -17.94 |
| Sep 30, 2025 | -3.96 |
| Jun 30, 2025 | -3.63 |
| Mar 31, 2025 | -3.60 |
| Dec 31, 2024 | -15.76 |
| Sep 30, 2024 | -3.61 |
| Jun 30, 2024 | -2.09 |
| Mar 31, 2024 | -4.03 |
| Dec 31, 2023 | -31.59 |
| Sep 30, 2023 | -2.85 |
| Jun 30, 2023 | -7.53 |
| Mar 31, 2023 | -10.72 |
| Dec 31, 2022 | -59.89 |
| Sep 30, 2022 | -14.40 |
| Jun 30, 2022 | -20.16 |
| Mar 31, 2022 | -27.49 |
| Dec 31, 2021 | -20.70 |
| Sep 30, 2021 | -15.00 |
| Jun 30, 2021 | -13.13 |